Search

Displaying results 5301 - 5310 of 7687 in total
  1. Drug

    Ipramidil

    go.drugbank.com/drugs/DB20454
    Experimental

    Ipramidil has a monoisotopic molecular weight of 256.12 Da.

  2. Drug

    Pexantel

    go.drugbank.com/drugs/DB20771
    Experimental

    Pexantel has a monoisotopic molecular weight of 210.17 Da.

  3. Drug

    Zilantel

    go.drugbank.com/drugs/DB20793
    Experimental

    Zilantel has a monoisotopic molecular weight of 664.11 Da.

  4. Drug

    Bleselumab

    go.drugbank.com/drugs/DB15253
    Investigational

    Bleselumab is under investigation in clinical trial NCT02921789 (Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney

  5. Drug

    Belfosdil

    go.drugbank.com/drugs/DB21327
    Experimental

    Belfosdil has a monoisotopic molecular weight of 548.3 Da.

  6. Drug

    Litomeglovir

    go.drugbank.com/drugs/DB21363
    Experimental

    Litomeglovir has a monoisotopic molecular weight of 498.19 Da.

  7. Drug

    Norgesterone

    go.drugbank.com/drugs/DB21409
    Experimental

    Norgesterone has a monoisotopic molecular weight of 300.21 Da.

  8. Drug

    Pitenodil

    go.drugbank.com/drugs/DB21442
    Experimental

    Pitenodil has a monoisotopic molecular weight of 353.18 Da.

  9. Drug

    Haloprogesterone

    go.drugbank.com/drugs/DB20259
    Experimental

    Haloprogesterone has a monoisotopic molecular weight of 410.13 Da.

  10. Drug

    Efonidipine

    go.drugbank.com/drugs/DB09235
    Investigational

    Efonidipine is a calcium channel blocker of the dihydropyridine class, commercialized by Shionogi & Co. (Japan). Initially, it was marketed in 1995 under the trade name, Landel. The drug has been shown to block T-type in addition to ...